Presented by Heather Hydzik, ND | November 5, 2025 at 12 PM Pacific

Since the 2002-2004 WHI trials linked hormone therapy to breast cancer, heart disease, and stroke, many women avoided treatment for menopausal symptoms. Later reanalysis (2008-2019) showed that early postmenopausal therapy lowered coronary disease and mortality, and estrogen alone reduced breast cancer risk-though this perspective never reached mainstream media. A 2024 study of 10 million women has further redefined hormone safety beyond age 65, highlighting risks and benefits by formulation and delivery. Urinary hormone testing can also reveal metabolism patterns tied to cancer risk. Together, these insights help clinicians individualize therapy to improve quality of life and longevity.

Learning Objectives:

• Update your knowledge on evolving perspectives of hormone therapy and breast risk
• Review WHI reanalysis showing different risks/benefits of estrogen than first reported
• Explore findings from a 2024 large-scale study of women >65 on cancer, CVD, dementia, and mortality
• Learn the safest hormone delivery methods and formulations
• Interpret urine hormone testing for breast health and risk reduction
• Review case examples with BHRT and a new non-hormonal option

Presented by Lylen Ferris, ND | November 12, 2025 at 11 AM Pacific

Menopause is a well-defined stage marked by the end of menstruation, while andropause reflects a more gradual change in testosterone in men. These natural life transitions may influence overall well-being and are part of the normal aging process. Developing a deeper understanding of these changes can help clinicians recognize patterns and provide informed, supportive care to patients.

In this session, Dr. Lylen Ferris, ND, Director of Clinical Education at Doctor's Data, will share perspectives on evaluating hormone balance with advanced laboratory assessments. The discussion will introduce two testing options from Doctor's Data - the Comprehensive Plus Salivary Hormone Profile and the Hormone & Urinary Metabolites Assessment Profile (HuMap™). Dr. Ferris will also review considerations for incorporating the cortisol awakening response (CAR) into salivary cortisol testing, along with lifestyle and nutrition factors that clinicians may wish to explore when supporting patients.

Learning Objectives:

• How natural hormonal transitions associated with aging may influence overall health in both men and women
• The role of saliva and urine testing in providing insights about hormone balance
• General lifestyle and nutrition considerations relevant to hormonal transitions

This is a Rupa University hosted event.